HTB

CROI 9 (Retrovirus) 2002

9th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Februrary 24-28 2002

New research points the way for future treatment of women with HIV

9th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Februrary 24-28 2002

Study results shed light on cardiovascular risks: role of antiretrovirals and metabolism of lipids and sugars

Switch to abacavir improves lipoatrophy

Potential use of niacin to reduce intra-abdominal fat

Further benefits shown with New-Fill for facial atrophy

Lipodystrophy associated with lower CD4+ T cell counts

Treatment interruptions

Analysis of cells from long term non-progressors points the way to using vaccines and STIs to restore immune response to HIV

Symposium on T cell turnover and thymic function

New drugs: perhaps some genuine excitement this time

T20 and beyond: inhibition of HIV attachment and fusion at the 9th CROI

Pharmacogenetics predict abacavir hypersensitivity

Pregnancy: growing body of evidence supports treating maternal disease

Peripheral neuropathy update

Further Retroconference reports and data on the web